The role of serum and dietary advanced glycation endproducts in relation to cardiac function and structure: The Hoorn Study
Nutrition, Metabolism & Cardiovascular Diseases Jul 30, 2021
Kremers SHM, Remmelzwaal S, Schalkwijk CG, et al. - In the present study, the researchers sought to examine the correlation of serum and dietary advanced glycation endproducts (AGEs) with cardiac function and structure after eight years of follow-up. Three hundred seventy Hoorn Study candidates (aged 66.4 ± 6.1, 47% women) were included. At baseline and after 8 years of follow-up, they measured serum protein-bound AGEs [N ε -(carboxymethyl)lysine, N ε -(carboxyethyl)lysine, and pentosidine], as well as echocardiography to evaluate left atrium volume index, left ventricle ejection fraction (LVEF), and left ventricle mass index. The authors discovered a stronger, non-significant, association between higher dietary (carboxyethyl)lysine and higher LVEF at follow-up in participants without cardiovascular disease (CVD) vs participants with CVD. Overall serum AGEs were longitudinally linked to impaired systolic function.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries